Jeong S H, Cho H J, Kim H S, Han J I, Lee D W, Kim C G, Kim J W
Department of Ophthalmology, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Konyang University College of Medicine, Seoul, South Korea.
Eye (Lond). 2017 Oct;31(10):1456-1462. doi: 10.1038/eye.2017.85. Epub 2017 May 26.
PurposeTo identify prognostic factors in patients referred with endophthalmitis after cataract surgery, and to evaluate the efficacy of primary vitrectomy as an initial management.MethodsOver an eight-year study period, we retrospectively reviewed the medical records of 164 patients who were referred with endophthalmitis following cataract surgery. Treatment generally conformed to standard guidelines, although primary vitrectomy was performed in several eyes with a visual acuity of hand motion or better, depending on the patient's status. Using multivariate analysis, we analyzed outcomes to determine the effect on final visual outcome.ResultsA final visual acuity of ≥20/40 was achieved in 92/164 (56.1%) cases after treatment. Bacterial cultures showed bacterial growth in 89/164 cases (54.3%). Among the various baseline characteristics, old age (P=0.028), poor visual acuity at presentation (P=0.004), gram-negative bacterial infection (P=0.030), and short time between cataract surgery and signs of endophthalmitis (P=0.021) were associated with poor visual outcome. The visual outcome showed no significant difference, in terms of initial treatment feature, between the primary vitrectomy with intraocular antibiotics injection (IOAI) and IOAI-only groups. However, reintervention was significantly less frequent in the primary vitrectomy group than in the IOAI group (12.5 and 32.7%, respectively; P=0.002).ConclusionOld age, poor visual acuity at presentation, type of cultured organism (gram-negative bacteria), and early onset of endophthalmitis after cataract surgery were significantly related to poor visual outcome after endophthalmitis treatment. Primary vitrectomy may decrease the need for reintervention to control infection, although the treatment showed no benefits with regard to visual outcome.
确定白内障手术后发生眼内炎患者的预后因素,并评估初始治疗采用一期玻璃体切除术的疗效。
在一项为期八年的研究期间,我们回顾性分析了164例白内障手术后发生眼内炎患者的病历。治疗一般遵循标准指南,不过根据患者情况,对部分视力为手动或更好的患眼实施了一期玻璃体切除术。我们采用多因素分析来分析结果,以确定其对最终视力预后的影响。
治疗后,164例患者中有92例(56.1%)最终视力≥20/40。细菌培养显示,164例中有89例(54.3%)有细菌生长。在各种基线特征中,高龄(P = 0.028)、就诊时视力差(P = 0.004)、革兰氏阴性菌感染(P = 0.030)以及白内障手术至眼内炎症状出现的时间短(P = 0.021)与视力预后差相关。就初始治疗方式而言,一期玻璃体切除术联合眼内抗生素注射(IOAI)组与单纯IOAI组的视力预后无显著差异。然而,一期玻璃体切除术组再次干预的频率显著低于IOAI组(分别为12.5%和32.7%;P = 0.002)。
高龄、就诊时视力差、培养出的病原体类型(革兰氏阴性菌)以及白内障手术后眼内炎的早期发作与眼内炎治疗后的视力预后差显著相关。一期玻璃体切除术可能会减少控制感染所需的再次干预,不过该治疗在视力预后方面并无益处。